Shionogi builds US women's health presence with Brisdelle co-pro deal
This article was originally published in Scrip
Executive Summary
Shionogi has signaled an increasing strategic interest in the women's health sector in the US through a deal for the co-promotion in this market of Noven Pharmaceuticals' Brisdelle (paroxetine).